Stockreport

MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies t [Read more]